AKS - Valeant Pharmaceuticals Is A Long-Term Buy - Cramer's Lightning Round (1/26/18)
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, January 26.
Bullish Calls
W.W. Grainger (GWW): They had a great quarter. It's a buy.
Maxim Integrated Products (MXIM): They are doing terrific. Don't sell it.
Valeant Pharmaceuticals (VRX): CEO Joe Papa is turning the company around. Hold it for the long term.
Andeavor Logistics (ANDX): "I think it's fine. I think the dividend's safe. I think people don't understand that group. I think you've got a winner. And I think that, actually, that whole group is starting to go